Jim Simons Evelo Biosciences, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$3.91 - $12.28 $112,099 - $352,067	-28,670 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.81 - $5.73 $27,813 - $41,829	-7,300 Reduced 20.29%	28,670 $151,000
Q2 2020 Aug 13, 2020	BUY	$3.53 - $6.12 $29,652 - $51,408	8,400 Added 30.47%	35,970 $176,000
Q1 2020 May 14, 2020	SELL	$3.21 - $7.06 $5,232 - $11,507	-1,630 Reduced 5.58%	27,570 $104,000
Q4 2019 Feb 13, 2020	BUY	$3.81 - $7.45 $56,007 - $109,515	14,700 Added 101.38%	29,200 $119,000
Q3 2019 Nov 13, 2019	BUY	$5.45 - $8.8 $79,025 - $127,600	14,500 New	14,500 $88,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.